SJRI To Participate at TCT 2007 Symposium.

Expertise of Scientific Staff Presents to Industry and Physicians

ATLANTA -- Saint Joseph's Research Institute (SJRI) is exhibiting and presenting its scientific investigations and findings to a global audience of allied physicians and medical device industry professionals during the 19th annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium being held in Washington D.C., October 20th - 25th. This is SJRI's first time exhibiting at the world's premier conference in interventional cardiology, endovascular medicine, and structural heart disease.

"We have spent many years refining our research staff and technical abilities to meet not only the needs of the scientific community but to aid in industry's advancements of their therapeutic portfolios," says Nicolas Chronos, MD, president of SJRI. "2007 has been the most exciting for SJRI as we have enriched our preclinical, clinical and educational capabilities to be able to move with the speed and efficiencies that are required with today's innovative technology. We have unique equipment and models that are positioning us as the premier investigational research center of excellence for collaborations and worldwide alliances."

Recent preclinical and clinical studies investigated by SJRI's expert scientists will be on the forefront of presentations from the podium and in abstract form. Topics being presented include extracellular cardiac repair, new drug carrier systems, bioabsorbability, ischemic heart disease, umbilical-cord derived stem cells, left ventricular (LV) function and dysfunction, novel carotid stent design, drug-eluting stents, polymers and coatings.

SJRI has extensive experience in class III medical device research, offers academic and industry-sponsored research and physician training by a staff comprised of scientists, physicians and health care professionals. With the erosion of positive long term data for drug-eluting stents, Saint Joseph's Research Institute continues working with a number of ongoing studies for second and third generation stents.

The business development team also will be showcasing SJRI's specialized capabilities in the evaluation of novel interventional technologies for coronary and peripheral diseases, as well as follow-up educational programming and physician training. Collaborative meetings will be conducted in a confidential setting with the preclinical and clinical staff consisting of MD's, PhD's and Post-Doctoral Fellows.

About Saint Joseph's Research Institute - Saint Joseph's Research Institute (SJRI), a subsidiary of Saint Joseph's Hospital, is a specialty research organization (SRO) engaged in academic and industry-sponsored research in both the preclinical and clinical settings. SJRI's innovative work helps move potential therapies, devices and drugs from the laboratory bench to the patient bedside faster using all available resources of the Saint Joseph's Health System. In addition to the proven research capabilities developed over the last decade, SJRI has enriched its services to enhance post-launch utilization via educational and physician training programs. Visit the website at: www.sjri.org.

About Transcatheter Cardiovascular Therapeutics Symposium - TCT is the world's premier conference in interventional cardiology, endovascular medicine, and structural heart disease, where the latest trends, research findings, and techniques are disseminated to practicing physicians from around the world. The symposium will feature live procedures originating from more than 25 leading US and international medical centers featuring world-renowned operators performing complex interventions. Cases will be presented with an interactive and thematic approach in three distinct tracks: Coronary, Endovascular, and Structural Heart Disease. Visit the website at: www.tct2007.com.